{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:38:37Z","timestamp":1791121117062,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3897,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1111\/j.0022-202x.2005.23657.x","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T16:32:53Z","timestamp":1111509173000},"page":"741-750","source":"Crossref","is-referenced-by-count":50,"title":["Resistance to Activation-Induced Cell Death and Bystander Cytotoxicity Via the Fas\/Fas Ligand Pathway Are Implicated in the Pathogenesis of Cutaneous T Cell Lymphomas"],"prefix":"10.1016","volume":"124","author":[{"given":"Xiao","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhashandra","family":"Talpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/MB:25:1:19","article-title":"The Fas\/Fas ligand system and cancer: Immune privilege and apoptosis","volume":"25","author":"Abrahams","year":"2003","journal-title":"Mol Biotechnol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+CD26-subset in the identification of circulating S\u00e9zary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/4779","article-title":"Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells","volume":"5","author":"Bossi","year":"1999","journal-title":"Nat Med"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.2000.01243.x","article-title":"Human T cells with a type-2 cytokine profile are resistant to apoptosis induced by primary activation: Consequences for immunopathogenesis","volume":"120","author":"Carbonari","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2002.110101.x","article-title":"\u2018Activation-induced cell death\u2019: A special program able to preserve the homeostasis of the skin?","volume":"11","author":"De Panfilis","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0035","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: A possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Dereure","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0040","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1365-2133.2000.03889.x","article-title":"Decreased expression of Fas (APO-1\/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas","volume":"143","author":"Dereure","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0045","first-page":"5817","article-title":"Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x (L) or Bcl-2","volume":"61","author":"Dirsch","year":"2001","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/cimm.1995.1122","article-title":"The molecular mechanism of FasL-mediated cytotoxicity by CD4+Th1 clones","volume":"163","author":"El-Khatib","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0055","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.4049\/jimmunol.164.10.5023","article-title":"Cutting edge: The tumor counterattack hypothesis revisited: Colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway","volume":"164","author":"Favre-Felix","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","article-title":"Activation-induced cell death in T cells","volume":"193","author":"Green","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/35103104","article-title":"The role of fas ligand in immune privilege","volume":"2","author":"Green","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0070","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0190-9622(92)70212-X","article-title":"Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy","volume":"27","author":"Heald","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.1994.01690020064010","article-title":"Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma","volume":"130","author":"Heald","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0085","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2002-07-2247","article-title":"Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and S\u00e9zary syndrome","volume":"101","author":"Herne","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32","article-title":"Association of erythrodermic cutaneous T cell lymphoma, superantigen-positive staphylococcus aureus, and oligoclonal T-cell receptor Vb gene expansion","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0095","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.182.6.1777","article-title":"Metalloproteinase-mediated release of human Fas ligand","volume":"182","author":"Kayagaki","year":"1995","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.135.1.26","article-title":"Clinical Characteristics and long-term outcome of patients with generalized patch or plaque (T2) mycosis fungoides","volume":"135","author":"Kim","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/smim.1996.0050","article-title":"The molecular regulation of lymphocyte apoptosis","volume":"9","author":"Lenardo","year":"1997","journal-title":"Semin Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2567.2002.01380.x","article-title":"Immune privilege and FasL: Two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells","volume":"105","author":"Li","year":"2002","journal-title":"Immunology"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.cdd.4400984","article-title":"The death of a T-cell: Expression of the CD95 ligand","volume":"9","author":"Li-Weber","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/intimm\/8.1.57","article-title":"Comparison of Fas(Apo-1\/CD95)-and perforin-mediated cytotoxicity in primary T lymphocytes","volume":"8","author":"Lowin","year":"1996","journal-title":"Int Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1440-1711.2002.01068.x","article-title":"Activation-induced cell death: The controversial role of Fas and Fas ligand in immune privilege and tumor counterattack","volume":"80","author":"Maher","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-1759(91)90325-A","article-title":"The JAM test. A simple assay for DNA fragmentation and cell death","volume":"145","author":"Matzinger","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2001.tb03710.x","article-title":"Reversible resistance to apoptosis in cutaneous T cell lymphoma","volume":"941","author":"Meech","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0140","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2567.2001.01264.x","article-title":"The regulation of FasL expression during activation-induced cell death (AICD)","volume":"103","author":"Nguyen","year":"2001","journal-title":"Immunology"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0150","first-page":"2682","article-title":"Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+cytotoxic T lymphocytes in mycosis fungoides: A potential mechanism of tumor immune escape?","volume":"7","author":"Ni","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/cimm.1997.1200","article-title":"Activation-induced T cell death: Resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype","volume":"181","author":"Oberg","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.184.3.1075","article-title":"The Fas counterattack: Fas-mediated T-cell killing by colon cancer cells expression Fas ligand","volume":"184","author":"O'Connell","year":"1996","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2141.2002.03382.x","article-title":"Differentiation of promyelocytic leukaemia: Alterations in Fas (CD95\/Apo-1) and Fas ligand (CD178) expression","volume":"117","author":"Salih","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0170","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.160.9.4159","article-title":"Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies","volume":"160","author":"Smith","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0175","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4049\/jimmunol.171.3.1172","article-title":"Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells","volume":"171","author":"Strauss","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0180","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.154.8.3806","article-title":"Expression of the Fas ligand in cells of T cell lineage","volume":"154","author":"Suda","year":"1995","journal-title":"J. Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3816\/CLM.2003.n.007","article-title":"A typical lymphoid infiltration occurring at the site of a healed varicella zoster infection","volume":"3","author":"Talpur","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2133.1974.tb12449.x","article-title":"Mycosis fungoides\u2014a disease of antigen persistence","volume":"91","author":"Tan","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00370726","article-title":"Genotraumatic T cells and cutaneous T-cell lymphoma. A causal relationship?","volume":"11","author":"Thestrup","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1523-1747.ep12371727","article-title":"Superantigenic Staphylococcal exotoxins induce T-cell proliferation in the presence of langerhans cells or class II bearing keratinocytes and stimulate keratinocytes to produce T-cell activating cytokines","volume":"102","author":"Tokura","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0205","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1073\/pnas.94.11.5778","article-title":"Differential ability of T cell subsets to undergo activation-induced cell death","volume":"94","author":"Varadhachary","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V90.1.12","article-title":"Constitutive expression of Fas (Apo-1\/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance","volume":"90","author":"Villunger","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by S\u00e9zary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0220","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/cimm.1997.1159","article-title":"CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL","volume":"179","author":"Wang","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6890-2-5","article-title":"A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy","volume":"2","author":"Washington","year":"2002","journal-title":"BMC Clin Pathol"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0235","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0025-5564(02)00120-7","article-title":"Cells behaving badly: A theoretical model for the Fas\/FasL system in tumour immunology","volume":"179","author":"Webb","year":"2002","journal-title":"Math Biosci"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0245","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action","volume":"8","author":"Zhang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.0022-202X.2005.23657.x_bb0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2133.2000.03656.x","article-title":"Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): Association between lack of Fas expression and aggressive types of CTCL","volume":"143","author":"Zoi-Toli","year":"2000","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15322429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15322429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:35:46Z","timestamp":1706070946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15322429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0022202X15322429"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2005.23657.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}